2003 Fiscal Year Final Research Report Summary
Intervention of interleukin to neuropathic pain
| Project/Area Number |
14571905
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Surgical dentistry
|
|---|
| Research Institution | Kyushu Dental College |
|---|
Principal Investigator |
SHIIBA Shunji Kyushu Dental College, Associate professor, 歯学部, 助手 (20285472)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
SAKAMOTO Eiji Kyushu Dental College, Associate professor, 歯学部, 助手 (00295859)
NAKANISHI Osamu Kyushu Dental College, Professor, 歯学部, 教授 (50137345)
|
|---|
| Project Period (FY) |
2002 – 2003
|
| Keywords | Neuropathic pain / Interleukin-6 / Inflammatory cytocaine / CCI / Dorsal Root Gangrion / Sciatic nerve / Neuritis / 疼痛関連行動 |
|---|
| Research Abstract |
It was clear that painful animal model, CFA(complete Freund's adjuvant) and CCI(choronic constriction injury) in sciatic nerve induced neuropathic pain. The pain-related behavior which these models lick hindpow and take escape behavior for heat radiation and a pin prick test. That these pain-related action is inhibited by administration of thalidomide of immunomodulator and cyclosporine S of an immunosuppressive drug, and a substance of inflammatory contributes to neuropathic pain is predicted. Therefore I paid attention to interleukin-6(IL-6) which contributed to neurotization deeply. I understood that a pain-related behavior for all algetic irritation was inhibited when I preloaded an antibody of IL-6. IL-6 developed in rat dorsal root ganglia, spinal dorsal root and nerve injury region from the immediately after which nerve damage caused. I became a peak after nerve damage in three days and continued it to 14 after a disorder. This immunostaining result accords with course of rat pain-related behavioral degree. Rat sciatic nerve exposed was soaked into IL-6 solution, and it developed a pain-related behavior as CCI and CFA painful model. Intervention of IL-6 to neuropathic pain became clear. Early administration of an IL-6 blocker after nerve injury is effective as a therapy of neuropathic pain.
|
